Biomedical Development Corporation is categorized under Commercial Biotechnical Research in Lexington, KY and active since 1984.
Biomedical Development Corporation was established in 1984, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Phyllis B Siegel at the company’s single location by writing to 145 Graham Avenue A272, Lexington, Kentucky KY 40506 or by phoning (210) 308-0636. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Biomedical Development Corporation |
Contact Person: | Phyllis B Siegel |
Address: | 145 Graham Avenue A272, Lexington, Kentucky 40506 |
Phone Number: | (210) 308-0636 |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1984 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Commercial Biotechnical Research |
SIC Code: | 8731 |
NAICS Code: | 541711 |
Share This Business: |
Biomedical Development Corporation was started in 1984 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Phyllis B Siegel for inquiries that concern Biomedical Development Corporation by calling the company number (210) 308-0636, as your correspondence is most welcome. Additionally, the physical location of the single location of Biomedical Development Corporation can be found at the coordinates 38.036225,-84.506544 as well as the street address 145 Graham Avenue A272 in Lexington, Kentucky 40506.
For its online presence, you may visit Biomedical Development Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.